What are you searching for ?

Business

Christmas Eve Trading: European Markets Rise, Novo Nordisk Recovers from Last Week’s Selloff

Christmas Eve Trading: European Markets Rise, Novo Nordisk Recovers from Last Week’s Selloff
 

European markets closed higher on Tuesday in a shortened trading session ahead of the Christmas holiday. The pan-European Stoxx 600 index ended the day 0.2% higher, with technology and mining stocks leading the gains. This followed a strong performance in U.S. markets on Monday, particularly in the technology sector.

 

Key Market Performances

  • FTSE 100 (London) and CAC 40 (France) both closed in positive territory, with broad sector gains.
  • Technology stocks were among the top performers, mirroring trends seen in the U.S. earlier in the week.

 

Novo Nordisk Leads the Stoxx 600

Novo Nordisk, the Danish pharmaceutical giant, emerged as the standout performer on Tuesday, with its shares surging 5.7% by the close of the session. The company’s stock recovery follows last week’s significant sell-off, which was triggered by disappointing trial results for its weight-loss drug, CagriSema.

 

AstraZeneca Withdraws EU Application for Lung Cancer Drug

In other pharmaceutical news, AstraZeneca announced the voluntary withdrawal of its EU marketing application for the lung cancer treatment, datopotamab deruxtecan. This decision, made alongside co-developer Daiichi Sankyo, came after feedback from the European Medicines Agency. The company’s stock saw a modest 0.1% increase by the close of trading.

 

Anglo American Faces Environmental Charges in Chile

Mining giant Anglo American is facing legal challenges in Chile, where the country’s Superintendency of the Environment (SMA) filed four environmental charges related to its Los Bronces copper mine. The charges could result in fines of up to $17 billion for alleged non-compliance with environmental permits. Despite the news, Anglo American’s London-listed shares closed 2% higher, buoyed by positive sentiment in the mining sector.

 

Vistry Group Suffers Heavy Losses

British homebuilder Vistry Group saw its shares plummet 16% on Tuesday after the company revised its full-year profit forecast. Citing delays in year-end transactions and completions, Vistry reduced its profit outlook by £50 million, now expecting an adjusted pre-tax profit of £250 million.

 

Other Notable Performances

  • Swedish gambling firm Evolution continued its downward trajectory, following news of a U.K. Gambling Commission review. The company’s shares remained under pressure after Monday’s sharp decline.
  • Mining stocks across Europe rallied after reports that China plans to issue a record 3 trillion yuan ($411 billion) in treasury bonds in 2025, boosting demand for raw materials.

 

Global Market Context

Overnight in Asia, markets were mixed as investors monitored key developments:

  • Japan’s monetary policy outlook remains uncertain.
  • A blockbuster merger between Honda and Nissan grabbed headlines, signaling major consolidation in the automotive sector.
  • South Korea’s consumer confidence faltered, adding to concerns about the region’s economic resilience.

 

Muted Trading Ahead of the Holidays

With multiple markets closing early on Tuesday and remaining closed on Wednesday for Christmas Day, trading volumes are expected to remain thin throughout the week.

 
 


Crypto and Metals



btc us81,833.1 USDBitcoin
eth us2,198.38 USDEthereum
xrp us2.08363 USDXRP
xau us2,873.07 USDGold Ounce
xag us31.3408 USDSilver Ounce
xpd us924.325 USDPalladium Ounce
xpt us955.219 USDPlatinum Ounce


Important Stocks >>




Latest News

Business

Shares of British aerospace giant Rolls-Royce hit a historic high on Thursday after the company announced better-than-expected financial results ..

Business

In a bold move during his second term as U.S. President, Donald Trump has announced plans to impose a ..

Business

The release of DeepSeek-R1, a groundbreaking AI model by Chinese company DeepSeek, has sent ripples across the AI industry, ..

Business

Bitcoin, the flagship cryptocurrency, has fallen to a three-month low, dropping below the critical $90,000 mark as risk-off sentiment ..